| (B) Stricture formation (narrowing of urethra (tube
from bladder to outside)).
(C) Need for additional surgery.
(19) Percutaneous nephrostomy/stenting/stone removal.
(A) Pneumothorax or other pleural complications (collapsed
lung or filling of the chest cavity on the same side with fluid).
(B) Septic shock/bacteremia (infection of the blood
stream with possible shock/severe lowering of blood pressure) when
pyonephrosis (infected urine in the kidney) present.
(C) Bowel (intestinal) injury.
(D) Blood vessel injury with or without significant
bleeding.
(20) Dialysis (technique to replace functions of kidney
and clean blood of toxins).
(A) Hemodialysis.
(i) Hypotension (low blood pressure).
(ii) Hypertension (high blood pressure).
(iii) Air embolism (air bubble in blood vessel) resulting
in possible death or paralysis.
(iv) Cardiac arrhythmias (irregular heart rhythms).
(v) Infections of blood stream, access site, or blood
borne (for example: Hepatitis B, C, or HIV).
(vi) Hemorrhage (severe bleeding as a result of clotting
problems or due to disconnection of the bloodline).
(vii) Nausea, vomiting, cramps, headaches, and mild
confusion during and/or temporarily after dialysis.
(viii) Allergic reactions.
(ix) Chemical imbalances and metabolic disorders (unintended
change in blood minerals).
(x) Pyrogenic reactions (fever).
(xi) Hemolysis (rupture of red blood cells).
(xii) Graft/fistula damage including bleeding, aneurysm,
formation (ballooning of vessel), clotting (closure) of graft/fistula.
(B) Peritoneal dialysis.
(i) Infections, including peritonitis (inflammation
or irritation of the tissue lining the inside wall of abdomen and
covering organs), catheter infection and catheter exit site infection.
(ii) Development of hernias of umbilicus (weakening
of abdominal wall or muscle).
(iii) Hypertension (high blood pressure).
(iv) Hypotension (low blood pressure).
(v) Hydrothorax (fluid in chest cavity).
(vi) Arrhythmia (irregular heart rhythm).
(vii) Perforation of the bowel.
(viii) Sclerosis or scarring of the peritoneum.
(ix) Weight gain leading to obesity.
(x) Abdominal discomfort/distension.
(xi) Heartburn or reflux.
(xii) Increase in need for anti-diabetic medication.
(xiii) Muscle weakness.
(xiv) Dehydration (extreme loss of body fluid).
(xv) Chemical imbalances and metabolic disorders (unintended
change in blood minerals).
(xvi) Allergic reactions.
(xvii) Nausea, vomiting, cramps, headaches, and mild
confusion during and/or temporarily after dialysis.
(q) Psychiatric procedures.
(1) Electroconvulsive therapy with modification by
intravenous muscle relaxants and sedatives.
(A) Memory changes of events prior to, during, and
immediately following the treatment.
(B) Fractures or dislocations of bones.
(C) Significant temporary confusion requiring special
care.
(2) Other Procedures. No other procedures are assigned
at this time.
(r) Radiation therapy. A child is defined for the purpose
of this subsection as an individual who is not physiologically mature
as determined by the physician using the appropriate medical parameters.
(1) Head and neck.
(A) Early reactions.
(i) Reduced and sticky saliva, loss of taste and appetite,
altered sense of smell, nausea.
(ii) Sore throat, difficulty swallowing, weight loss,
fatigue.
(iii) Skin changes: redness, irritation, scaliness,
blistering or ulceration, color change, thickening, hair loss.
(iv) Hoarseness, cough, loss of voice, and swelling
of airway.
(v) Blockage and crusting of nasal passages.
(vi) Inflammation of ear canal, feeling of "stopped
up" ear, hearing loss, dizziness.
(vii) Dry and irritable eye(s).
(viii) In children, these reactions are likely to be
intensified by chemotherapy before, during or after radiation therapy.
(ix) In children, depression of blood count leading
to increased risk of infection and/or bleeding is more common.
(B) Late reactions.
(i) Dry mouth and altered sense, or loss, of taste.
(ii) Tooth decay and gum changes.
(iii) Bone damage, especially in jaws.
(iv) Stiffness and limitation of jaw movement.
(v) Changes in skin texture and/or coloration, permanent
hair loss, and scarring of skin.
(vi) Swelling of tissues, particularly under the chin.
(vii) Throat damage causing hoarseness, pain or difficulty
breathing or swallowing.
(viii) Eye damage causing dry eye(s), cataract, loss
of vision, or loss of eye(s).
(ix) Ear damage causing dryness of ear canal, fluid
collection in middle ear, hearing loss.
(x) Brain, spinal cord or nerve damage causing alteration
of thinking ability or memory, and/or loss of strength, feeling or
coordination in any part of the body.
(xi) Pituitary or thyroid gland damage requiring long-term
hormone replacement therapy.
(xii) In children, there may be additional late reactions.
(I) Disturbance of bone and tissue growth.
(II) Bone damage to face causing abnormal development.
(III) Brain damage causing a loss of intellectual ability,
learning capacity, and reduced intelligence quotient (IQ).
(IV) Second cancers developing in the irradiated area.
(2) Central nervous system.
(A) Early reactions.
(i) Skin and scalp reaction with redness, irritation,
scaliness, blistering, ulceration, change in color, thickening, hair
loss.
(ii) Nausea, vomiting, headaches.
(iii) Fatigue, drowsiness.
(iv) Altered sense of taste or smell.
(v) Inflammation of ear canal, feeling of "stopped-up"
ear, hearing loss, dizziness.
(vi) Depression of blood count leading to increased
risk of infection and/or bleeding.
(vii) In children, these reactions are likely to be
intensified by chemotherapy before, during or after radiation therapy.
(viii) In children, depression of blood count leading
to increased risk of infection and/or bleeding is more common.
(B) Late reactions.
(i) Permanent hair loss of variable degrees, altered
regrowth, texture and color of hair.
(ii) Persistent drowsiness and tiredness.
(iii) Brain damage causing a loss of some degree of
thinking ability or memory, or personality changes.
(iv) Scarring of skin.
(v) Spinal cord or nerve damage causing loss of strength,
feeling or coordination in any part of the body.
(vi) Damage to eye(s), or optic nerve(s) causing loss
of vision.
(vii) Ear damage causing dryness of ear canal, fluid
collection in middle ear, hearing loss.
(viii) Pituitary gland damage requiring long-term hormone
replacement therapy.
(ix) In children, there may be additional late reactions.
(I) Disturbances of bone and tissue growth.
(II) Bone damage to spine, causing stunting of growth,
curvature and/or reduction in height.
(III) Bone damage to face, or pelvis causing stunting
of bone growth and/or abnormal development.
(IV) Brain damage causing a loss of intellectual ability,
learning capacity, and reduced intelligence quotient (IQ).
(V) Second cancers developing in the irradiated area.
(3) Thorax.
(A) Early reactions.
(i) Skin changes: redness, irritation, scaliness, ulceration,
change in color, thickening, hair loss.
(ii) Inflammation of esophagus causing pain on swallowing,
heartburn, or sense of obstruction.
(iii) Loss of appetite, nausea, vomiting.
(iv) Weight loss, weakness, vomiting.
Cont'd... |
